NO | Term | count | P-Value | Genes |
---|---|---|---|---|
1 | hsa05200: 21Pathways in cancer | 10 | 9.90 × 10–4 | E2F1、AR、CCND1、HSP90AA1、BCR、RAC1、RARA、STK4、TRAF4、CDK2 |
2 | hsa05215: Prostate cancer | 5 | 3.50 × 10–4 | E2F1、AR、CCND1、HSP90AA1、CDK2 |
3 | hsa00480: Glutathione metabolism | 4 | 8.60 × 10–4 | ODC1、RRM1、IDH2、IDH1 |
4 | hsa05223: Non-small cell lung cancer | 4 | 1.30 × 10–3 | E2F1、CCND1、ALK、STK4 |
5 | hsa04115: p53 signalling pathway | 4 | 2.50 × 10–3 | CCND1、THBS1、CDK2、TP73 |
6 | hsa05222: Small cell lung cancer | 4 | 4.90 × 10–3 | E2F1、CCND1、TRAF4、CDK2 |
7 | hsa04151: PI3K-Akt signaling pathway | 6 | 9.10 × 10–3 | CCND1、HSP90AA1、RAC1、THBS1、INSR、CDK2 |
8 | hsa05219: Bladder cancer | 3 | 1.10 × 10–2 | E2F1、CCND1、THBS1 |
9 | hsa04110: Cell cycle | 4 | 1.20 × 10–2 | E2F1、CCND1、CCNA2、CDK2 |
10 | hsa04068: FoxO signaling pathway | 4 | 1.30 × 10–2 | CCND1、STK4、INSR、CDK2 |
11 | hsa05161: Hepatitis B | 4 | 2.00 × 10–2 | E2F1、CCND1、CCNA2、CDK2 |
12 | hsa05212: Pancreatic cancer | 3 | 2.80 × 10–2 | E2F1、CCND1、RAC1 |
13 | hsa05220: Chronic myeloid leukemia | 3 | 3.40 × 10–2 | E2F1、CCND1、BCR |
14 | hsa05205: Proteoglycans in cancer | 4 | 4.20 × 10–2 | CCND1、RAC1、ESR1、THBS1 |
15 | hsa05203: Viral carcinogenesis | 4 | 4.20 × 10–2 | CCND1、RAC1、CCNA2、CDK2 |
16 | hsa04914: Progesterone-mediated oocyte maturation | 3 | 4.30 × 10–2 | HSP90AA1、CCNA2、CDK2 |
17 | hsa01210: 2-Oxocarboxylic acid metabolism | 2 | 6.00 × 10–2 | IDH2、IDH1 |
18 | hsa04919: Thyroid hormone signaling pathway | 3 | 7.30 × 10–2 | NOTCH1、CCND1、ESR1 |
19 | hsa04152: AMPK signaling pathway | 3 | 7.90 × 10–2 | CCND1、CCNA2、INSR |
20 | hsa05162: Measles | 3 | 9.60 × 10–2 | CCND1、CDK2、TP73 |
21 | hsa05206: MicroRNAs in cancer | 4 | 8.00 × 10–2 | E2F1、NOTCH1、CCND1、THBS1 |